To contact NxStage call 1-866-NXSTAGE. To speak with a Patient Consultant about home therapies call 1-888-200-6456 or text INFO to 1-844-620-2267.
After Don began in-center dialysis in 2012, he was always feeling tired and couldn’t get anything done. He fell into a really dark place. But everything changed when he began more frequent home hemodialysis with System One. With the help of his mom – his care partner – he regained his life. Now he’s playing tennis, running upstairs, riding his motorcycle and – most importantly – playing with his grandkids again.
The reported benefits of home hemodialysis (HHD) may not be experienced by all patients.
The NxStage System is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.
Home hemodialysis with the NxStage System during waking hours may not require a care partner, provided a physician and a qualified patient agree that solo home hemodialysis is appropriate. Patients performing nocturnal treatments are required to have a care partner. Care partners are trained on proper operation and how to get medical or technical help if needed.
Certain risks associated with hemodialysis treatment are increased when performing solo HHD because no one is present to help the patient respond to health emergencies. If patients experience needles coming out, blood loss, or very low blood pressure during solo HHD, they may lose consciousness or become physically unable to correct the health emergency. Losing consciousness or otherwise becoming impaired during any health emergency while alone could result in significant injury or death. Additional ancillary devices and training are required when performing solo HHD.
Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow and/or increased treatment time, and delayed response to alarms when waking from sleep.
Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.
